A Look At Universal Technical Institute (UTI) Valuation After Its Strong Year To Date Share Price Run

What Universal Technical Institute stock’s recent move might be telling you

Universal Technical Institute (UTI) sits in a specialized corner of education, focused on transportation, skilled trades, and healthcare training, which gives its stock a different profile than many consumer services peers.

Over the past month, the stock gained about 8%, while the past 3 months show a roughly 13% return and year to date it is up about 60%, setting a very strong recent performance backdrop.

At a recent close of US$39.75, UTI’s market value stands near US$2.16b, supported by annual revenue of about US$868.99m and net income of about US$42.68m from its UTI and Concorde segments.

Revenue is primarily generated in the United States. The UTI segment contributed about US$561.67m and Concorde Career Colleges added about US$307.31m, reflecting a business focused on domestic vocational and healthcare education programs.

Annual revenue growth of about 8.7% and net income growth of about 24.6% indicate that earnings have been moving faster than sales, which can matter for investors watching profitability trends in education providers.

See our latest analysis for Universal Technical Institute.

In the short term, the 1 day share price return of 1.2% and 7 day share price decline of 10.7% sit against a much stronger year to date share price return of 60%. Total shareholder returns over three and five years are both very large, which points to long term momentum even as near term sentiment cools slightly.

If this kind of performance has you thinking about what else is moving, it could be a good moment to broaden your search with 19 top founder-led companies

With UTI trading near US$39.75 after a strong year to date run and sitting only modestly below a US$42.50 analyst target, the key question now is whether there is still a buying opportunity or if the market is already pricing in future growth.

Most Popular Narrative: 6.5% Undervalued

At a last close of US$39.75 against a narrative fair value of US$42.50, the widely followed view frames UTI as modestly undervalued and heavily shaped by growth and index inclusion themes.

The recently lifted growth restrictions on Concorde Career Colleges now allow for accelerated program launches and the addition of multiple new campuses a year ahead of plan, positioning the company for faster-than-anticipated revenue growth and increased market share starting as early as 2026. Federal regulatory priorities and new legislation (such as expanded Pell Grant eligibility for short-term credential programs) are improving student affordability and access, enabling UTI to expand into new short-course offerings that were previously untapped, supporting long-term enrollment growth and future revenue diversification.

Read the complete narrative.

Want to see what sits behind that fair value gap? The narrative refers to compounded earnings growth, rising margins, and a richer future P/E than the wider consumer services group.

Result: Fair Value of US$42.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this hinges on execution, as heavier campus expansion and any shift in federal student aid rules could quickly challenge the current growth-driven narrative.

Find out about the key risks to this Universal Technical Institute narrative.

Another Angle On What The Market Is Paying For UTI

The narrative argues UTI is about 6.5% undervalued at US$39.75 versus a fair value of US$42.50, but current pricing tells a different story. The stock trades on a P/E of 51.3x, well above the Consumer Services average of 16.6x and a fair ratio of 26.3x, which points to rich expectations and less room for error. How comfortable are you paying that kind of premium for this earnings profile?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Given the mixed signals on value, risk, and recent performance, it makes sense to review the underlying data yourself and act promptly. To see both sides of the story in one place, start with 1 key reward and 2 important warning signs

Looking for more investment ideas?

If UTI has caught your attention, do not stop here, some of the most compelling opportunities appear when you compare it with other stocks using targeted screeners.

• Spot potential value opportunities early by reviewing 47 high quality undervalued stocks that combine pricing appeal with solid fundamentals.
• Focus on stability and sleep easier at night by checking 63 resilient stocks with low risk scores designed to highlight companies with lower risk scores.
• Get ahead of the crowd by scanning screener containing 20 high quality undiscovered gems that aim to reveal quality stocks still flying under the radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com